Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Cara Therapeutics, Inc.    CARA

CARA THERAPEUTICS, INC.

(CARA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société CARA THERAPEUTICS, INC.
02/25CARA : 4Q Earnings Snapshot
AQ
02/25CARA THERAPEUTICS  : Management's Discussion and Analysis of Financial Condition..
AQ
02/25CARA THERAPEUTICS, INC.  : Results of Operations and Financial Condition (form 8..
AQ
02/25CARA THERAPEUTICS  : Reports Fourth Quarter and Full Year 2020 Financial Results
AQ
02/18Cara Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Res..
GL
01/12CARA THERAPEUTICS  : Initiates Phase 2 Trial of Oral KORSUVA for the Treatment o..
AQ
01/11Cara Initiates Phase 2 Trial of Oral KORSUVA™ for the Treatment of Prur..
GL
01/06CARA THERAPEUTICS  : to Present at the 39th Annual J.P. Morgan Healthcare Confer..
AQ
2020CARA THERAPEUTICS  : Submits New Drug Application to U.S. Food and Drug Administ..
AQ
2020CARA THERAPEUTICS, INC.  : Regulation FD Disclosure, Financial Statements and Ex..
AQ
2020Cara Therapeutics Submits New Drug Application to U.S. Food and Drug Administ..
GL
2020CARA THERAPEUTICS  : SWK Holdings' Subsidiary, Enteris BioPharma, Receives Secon..
PR
2020CARA THERAPEUTICS  : Completes Full Enrollment in KARE Phase 2 Trial of Oral KOR..
AQ
2020Cara Therapeutics Completes Full Enrollment in KARE Phase 2 Trial of Oral KOR..
GL
2020CARA THERAPEUTICS  : to Present at Multiple Upcoming Investor Conferences
AQ
2020Cara Therapeutics to Present at Multiple Upcoming Investor Conferences
GL
2020CARA THERAPEUTICS  : Management's Discussion and Analysis of Financial Condition..
AQ
2020CARA : 3Q Earnings Snapshot
AQ
2020CARA THERAPEUTICS, INC.  : Results of Operations and Financial Condition, Financ..
AQ
2020CARA THERAPEUTICS  : Reports Third Quarter 2020 Financial Results
AQ
2020Cara Therapeutics Reports Third Quarter 2020 Financial Results
GL
2020CARA THERAPEUTICS  : to Announce Third Quarter 2020 Financial Results on Novembe..
AQ
2020Cara Therapeutics to Announce Third Quarter 2020 Financial Results on Novembe..
GL
2020CARA THERAPEUTICS  : SWK Holdings' Subsidiary, Enteris BioPharma, Receives Miles..
PR
2020CARA THERAPEUTICS  : Announces Presentation at American Society of Nephrology Ki..
AQ
2020CARA THERAPEUTICS  : Announces Presentation at American Society of Nephrology Ki..
AQ
2020Cara Therapeutics Announces Presentation at American Society of Nephrology Ki..
GL
2020CARA THERAPEUTICS  : Vifor pharma and cara therapeutics sign us license agreemen..
AQ
2020Vifor Pharma and Cara Therapeutics sign US license agreement for IV Korsuva t..
AQ
2020CARA THERAPEUTICS  : and Vifor Pharma License Agreement Presentation
PU
2020CARA THERAPEUTICS, INC.  : Entry into a Material Definitive Agreement, Unregiste..
AQ
2020CARA THERAPEUTICS  : Vifor Pharma and Cara Therapeutics sign US license agreemen..
AQ
2020Vifor Pharma and Cara Therapeutics sign US license agreement for IV Korsuva&..
GL
2020TITAN PHARMACEUTICALS  : Provides a Strategic and Corporate Update
AQ
2020CARA THERAPEUTICS  : Appoints Thomas Reilly as Chief Financial Officer
AQ
2020CARA THERAPEUTICS, INC.  : Change in Directors or Principal Officers, Regulation..
AQ
2020CARA THERAPEUTICS  : Appoints Thomas Reilly as Chief Financial Officer
AQ
2020Cara Therapeutics Appoints Thomas Reilly as Chief Financial Officer
GL
2020CARA THERAPEUTICS  : Submission of Matters to a Vote of Security Holders (form 8..
AQ
2020CARA : 2Q Earnings Snapshot
AQ
2020CARA THERAPEUTICS  : Management's Discussion and Analysis of Financial Condition..
AQ
2020CARA THERAPEUTICS, INC.  : Results of Operations and Financial Condition, Financ..
AQ
2020Cara Therapeutics Reports Second Quarter 2020 Financial Results
GL
2020Cara Therapeutics to Present at the Canaccord Genuity 40th Annual Growth Conf..
GL
2020Cara Therapeutics to Announce Second Quarter 2020 Financial Results on August..
GL
2020CARA THERAPEUTICS, INC.  : Change in Directors or Principal Officers (form 8-K)
AQ
2020Cara Therapeutics Expands Board of Directors with Appointment of Susan Shiff,..
GL
2020CARA THERAPEUTICS  : Announces Completion of Interim Statistical Assessment for ..
AQ
2020CARA THERAPEUTICS, INC.  : Other Events (form 8-K)
AQ
2020Cara Therapeutics Announces Completion of Interim Statistical Assessment for ..
GL
2020CARA THERAPEUTICS, INC.  : Submission of Matters to a Vote of Security Holders (..
AQ
2020CARA THERAPEUTICS  : 4
PU
2020Cara Therapeutics to Present at the Jefferies Virtual Healthcare Conference
GL
2020CARA : 1Q Earnings Snapshot
AQ
2020CARA THERAPEUTICS  : Management's Discussion and Analysis of Financial Condition..
AQ
2020CARA THERAPEUTICS, INC.  : Results of Operations and Financial Condition (form 8..
AQ
2020Cara Therapeutics Reports First Quarter 2020 Financial Results
GL
2020Cara Therapeutics to Present at the Virtual BofA Securities 2020 Health Care ..
GL
2020Cara Therapeutics to Announce First Quarter 2020 Financial Results on May 11,..
GL
2020CARA THERAPEUTICS  : VFMCRP and Cara Therapeutics announce positive results from..
AQ
2020Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma Announce Posi..
AQ
2020CARA THERAPEUTICS, INC.  : Regulation FD Disclosure, Other Events, Financial Sta..
AQ
2020CARA THERAPEUTICS  : VFMCRP and Cara Therapeutics announce positive results from..
BU
2020Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma Announce Posi..
GL
2020Cara Therapeutics to Present at the Virtual 19th Annual Needham Healthcare Co..
GL
2020CARA THERAPEUTICS, INC.  : Other Events (form 8-K)
AQ
2020Cara Therapeutics Reports Clinical Updates
GL
2020CARA THERAPEUTICS  : Management's Discussion and Analysis of Financial Condition..
AQ
2020CARA : 4Q Earnings Snapshot
AQ
2020CARA THERAPEUTICS, INC.  : Results of Operations and Financial Condition, Financ..
AQ
2020Cara Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
GL
2020Cara Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Res..
GL
2020CARA THERAPEUTICS, INC.  : Regulation FD Disclosure (form 8-K)
AQ
2020CARA THERAPEUTICS  : to Present at the 38th Annual J.P. Morgan Healthcare Confer..
AQ
2019CARA THERAPEUTICS, INC.  : Change in Directors or Principal Officers (form 8-K)
AQ
1  2  3  4Next
Upcoming event on CARA THERAPEUTICS, INC.